- NLM Classification (23)
- QV Pharmacology, toxicology, pharmacy (335)
- QV 77 Psychopharmacology (5)
- QV Pharmacology, toxicology, pharmacy (335)
Krebs, E.E. and Gaynes, B.N. and Gartlehner, G. and Hansen, R.A. and Thieda, P. and Morgan, L.C. and de Veaugh-Geiss, A. and Lohr, K.N. (2008): Treating the physical symptoms of depression with second-generation antidepressants: A systematic review and metaanalysis. Psychosomatics: The Journal of Consultation and Liaison Psychiatry 49 (3): pp. 191-198.
Rothschedl, E. and Grössmann, N. (2023): Pembrolizumab (Keytruda®) with trastuzumab, fluoropyrimidine and platinum-containing chemotherapy for the first-line treatment of locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction (GEJ) adenocarcinoma. Update July/August 2023. Fact Sheet Nr. 145.
Winkler, R. (2018): Dropouts in Psychotherapy. Part I: Predictors, theories and models to explain and recommend courses of action to avoid discontinuation of therapy. Part II: "Overview of Reviews" on dropouts in psychotherapy. HTA-Projektbericht 100.
Zechmeister-Koss, I. and Kern, J. and Edlinger, M. (2024): Uptake of Mental Health Benefits in Women Before and During the Perinatal Period: An Analysis of Austrian Health Insurance Data. HTA-Projektbericht 154.
Zechmeister-Koss, I. and Tüchler, H. (2018): Prevalence of mental disorders and uptake of mental health services in Tyrol: An analysis of epidemiological literature and administrative data from the Tyrolean health insurance. HTA-Projektbericht 113b.